Loading chart…
PRE-MARKET
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, anti-infective, anti-bacterial, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics in the form of tablets, capsules, injectables, dry syrups, sprays, ointments etc.
Lincoln Pharmaceuticals Limited (LINCOLN) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The LINCOLN share price is ₹513.70 (+0.22% today), with a market capitalisation of ₹10B and a price-to-earnings (P/E) ratio of 10.6. MarketRipple tracks the LINCOLN investment thesis, the ripple-chain impact of market events on Lincoln Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹514.00
High
₹515.95
Low
₹508.10
Prev. Close
₹512.55
52W High
₹770.00
52W Low
₹440.00
Day range
₹508.10–₹515.95
52-week range
₹440.00–₹770.00
Volume
6K
P/E
10.6
ROE
12.7%
D/E
0.01
Margin
13.4%
Lincoln Pharmaceuticals Limited (NSE: LINCOLN) is currently trading at ₹513.70 (+0.22%).
Lincoln Pharmaceuticals Limited's market capitalization is ₹10B.
Lincoln Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 10.6.
Lincoln Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).